Brodie A M, Longcope C
Endocrinology. 1980 Jan;106(1):19-21. doi: 10.1210/endo-106-1-19.
To determine the effect of aromatase inhibitors on peripheral aromatization, male rhesus monkeys were infused with [7-3H]androstenedione and [4-14C]estrone before and during treatment with 4-hdyroxy-androstene-3,17-dione (50 mg/kg each; four monkeys) or 4-acetoxy-androstene-3,17-dione (700 mg each; two monkeys). In all six monkeys, no specific effects on the MCRs of androstenedione and estrone, the interconversion of androgens or estrogens, or androstenedione conversion to dihydrotestosterone were noted. In five of the six animals, aromatization rates were reduced by up to 97% of control values. The results demonstrate that these compounds inhibit peripheral aromatization and, together with our other results, suggest that aromatase inhibitors may be a useful treatment for estrogen-dependent cancer.
为了确定芳香化酶抑制剂对外周芳香化作用的影响,在雄性恒河猴接受4-羟基雄烯二酮(每只50mg/kg;4只猴子)或4-乙酰氧基雄烯二酮(每只700mg;2只猴子)治疗之前及治疗期间,给它们注射[7-³H]雄烯二酮和[4-¹⁴C]雌酮。在所有6只猴子中,未观察到对雄烯二酮和雌酮代谢清除率、雄激素或雌激素的相互转化,以及雄烯二酮转化为双氢睾酮有任何特异性影响。在6只动物中的5只,芳香化率降低至对照值的97%。结果表明,这些化合物可抑制外周芳香化作用,并且结合我们的其他结果提示,芳香化酶抑制剂可能是雌激素依赖性癌症的一种有效治疗方法。